TrialPloS one2022

Effect of switching from nucleos(t)ide maintenance therapy to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomized trial.

Hyun Young Woo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.